288 related articles for article (PubMed ID: 24643128)
41. Importance of transient receptor potential vanilloid 4 (TRPV4) in epidermal barrier function in human skin keratinocytes.
Kida N; Sokabe T; Kashio M; Haruna K; Mizuno Y; Suga Y; Nishikawa K; Kanamaru A; Hongo M; Oba A; Tominaga M
Pflugers Arch; 2012 Apr; 463(5):715-25. PubMed ID: 22374181
[TBL] [Abstract][Full Text] [Related]
42. Expression of cell-cycle proteins p53, p21 (WAF-1), PCNA and Ki-67 in benign, premalignant and malignant skin lesions with implicated HPV involvement.
Lu S; Tiekso J; Hietanen S; Syrjänen K; Havu VK; Syrjänen S
Acta Derm Venereol; 1999 Jul; 79(4):268-73. PubMed ID: 10429981
[TBL] [Abstract][Full Text] [Related]
43. Strong expression of a longevity-related protein, SIRT1, in Bowen's disease.
Hida Y; Kubo Y; Murao K; Arase S
Arch Dermatol Res; 2007 May; 299(2):103-6. PubMed ID: 17180656
[TBL] [Abstract][Full Text] [Related]
44. Multicellular origin of tenascin in skin tumors--an in situ hybridization study.
Tuominen H; Pöllänen R; Kallioinen M
J Cutan Pathol; 1997 Nov; 24(10):590-6. PubMed ID: 9449485
[TBL] [Abstract][Full Text] [Related]
45. TRPV4 Channel-Regulated ATP Release Contributes to γ-Irradiation-Induced Production of IL-6 and IL-8 in Epidermal Keratinocytes.
Ohsaki A; Tanuma SI; Tsukimoto M
Biol Pharm Bull; 2018 Oct; 41(10):1620-1626. PubMed ID: 30022772
[TBL] [Abstract][Full Text] [Related]
46. Analysis of p53 and bcl-2 protein expression in the non-tumorigenic, pretumorigenic, and tumorigenic keratinocytic hyperproliferative lesions.
Hussein MR; Al-Badaiwy ZH; Guirguis MN
J Cutan Pathol; 2004 Nov; 31(10):643-51. PubMed ID: 15491323
[TBL] [Abstract][Full Text] [Related]
47. Precursors to skin cancer.
Sober AJ; Burstein JM
Cancer; 1995 Jan; 75(2 Suppl):645-50. PubMed ID: 7804989
[TBL] [Abstract][Full Text] [Related]
48. The human transient receptor potential vanilloid 3 channel is sensitized via the ERK pathway.
Vyklicka L; Boukalova S; Macikova L; Chvojka S; Vlachova V
J Biol Chem; 2017 Dec; 292(51):21083-21091. PubMed ID: 29084846
[TBL] [Abstract][Full Text] [Related]
49. Osteopontin expression in normal skin and non-melanoma skin tumors.
Chang PL; Harkins L; Hsieh YH; Hicks P; Sappayatosok K; Yodsanga S; Swasdison S; Chambers AF; Elmets CA; Ho KJ
J Histochem Cytochem; 2008 Jan; 56(1):57-66. PubMed ID: 17938278
[TBL] [Abstract][Full Text] [Related]
50. p53 immunoreactivity in cutaneous PUVA tumors is similar to that in other non-melanoma skin neoplasms.
Proby CM; du Peloux Menagé H; McGregor JM; Hobbs C; Norris PG; Smith N; Hawk JL; McKee PH
J Cutan Pathol; 1993 Oct; 20(5):435-41. PubMed ID: 8300928
[TBL] [Abstract][Full Text] [Related]
51. An overview of Bcl-2 expression in histopathological variants of basal cell carcinoma, squamous cell carcinoma, actinic keratosis and seborrheic keratosis.
Puizina-Ivić N; Sapunar D; Marasović D; Mirić L
Coll Antropol; 2008 Oct; 32 Suppl 2():61-5. PubMed ID: 19138009
[TBL] [Abstract][Full Text] [Related]
52. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.
Park HR; Min SK; Min K; Jun SY; Seo J; Kim KH; Choi J
Int J Dermatol; 2010 Jan; 49(1):48-52. PubMed ID: 20465611
[TBL] [Abstract][Full Text] [Related]
53. Transient receptor potential vanilloid 4 (TRPV4)-dependent calcium influx and ATP release in mouse oesophageal keratinocytes.
Mihara H; Boudaka A; Sugiyama T; Moriyama Y; Tominaga M
J Physiol; 2011 Jul; 589(Pt 14):3471-82. PubMed ID: 21540339
[TBL] [Abstract][Full Text] [Related]
54. Insulin-like growth factor-binding protein-7 (IGFBP7) transcript: A-to-I editing events in normal and cancerous human keratinocytes.
Hochberg M; Gilead L; Markel G; Nemlich Y; Feiler Y; Enk CD; Denichenko P; Karni R; Ingber A
Arch Dermatol Res; 2013 Aug; 305(6):519-28. PubMed ID: 23543219
[TBL] [Abstract][Full Text] [Related]
55. Plasma membrane stretch activates transient receptor potential vanilloid and ankyrin channels in Merkel cells from hamster buccal mucosa.
Soya M; Sato M; Sobhan U; Tsumura M; Ichinohe T; Tazaki M; Shibukawa Y
Cell Calcium; 2014 Apr; 55(4):208-18. PubMed ID: 24642224
[TBL] [Abstract][Full Text] [Related]
56. Warm temperatures activate TRPV4 in mouse 308 keratinocytes.
Chung MK; Lee H; Caterina MJ
J Biol Chem; 2003 Aug; 278(34):32037-46. PubMed ID: 12783886
[TBL] [Abstract][Full Text] [Related]
57. Interleukin-8 immunoreactivity in malignant tumours of the skin.
Bornscheuer E; Schröder JM; Christophers E; Sticherling M
Acta Derm Venereol; 1996 May; 76(3):210-3. PubMed ID: 8800301
[TBL] [Abstract][Full Text] [Related]
58. Immunoreactivity to CYP24A1, but not vitamin D receptor, is increased in mast cells of keratinocyte skin cancers.
Kaukinen A; Siiskonen H; Pelkonen J; Harvima IT
Eur J Dermatol; 2017 Dec; 27(6):590-598. PubMed ID: 29165303
[TBL] [Abstract][Full Text] [Related]
59. P2Y1 Receptor Activation of the TRPV4 Ion Channel Enhances Purinergic Signaling in Satellite Glial Cells.
Rajasekhar P; Poole DP; Liedtke W; Bunnett NW; Veldhuis NA
J Biol Chem; 2015 Nov; 290(48):29051-62. PubMed ID: 26475857
[TBL] [Abstract][Full Text] [Related]
60. Immunohistochemical localization of the neutral cysteine protease bleomycin hydrolase in human skin.
Takeda A; Nonaka M; Ishikawa A; Higuchi D
Arch Dermatol Res; 1999 Apr; 291(4):238-40. PubMed ID: 10335922
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
